In the last trading session, 4.14 million shares of the Plus Therapeutics Inc (NASDAQ:PSTV) were traded, and its beta was 0.64. Most recently the company’s share price was $0.3, and it changed around -$0.01 or -3.52% from the last close, which brings the market valuation of the company to $15.12M. PSTV currently trades at a discount to its 52-week high of $2.31, offering almost -670.0% off that amount. The share price’s 52-week low was $0.16, which indicates that the current value has risen by an impressive 46.67% since then. We note from Plus Therapeutics Inc’s average daily trading volume that its 10-day average is 114.07 million shares, with the 3-month average coming to 24.44 million.
Plus Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended PSTV as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV has showed a red trend with a performance of -3.52% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3650 on recent trading dayincreased the stock’s daily price by 17.81%. The company’s shares are currently down -80.24% year-to-date, but still down -19.15% over the last five days. On the other hand, Plus Therapeutics Inc (NASDAQ:PSTV) is -21.77% down in the 30-day period. We can see from the shorts that 1.17 million shares have been sold at a short interest cover period of 0.1 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 46.51%. Plus Therapeutics Inc earnings are expected to increase by 55.00% in 2025, but the outlook is positive 53.45% per year for the next five years.
PSTV Dividends
Plus Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-30.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.02% of Plus Therapeutics Inc shares, and 2.50% of them are in the hands of institutional investors. The stock currently has a share float of 2.55%. Plus Therapeutics Inc stock is held by 17.0 institutions, with AIGH CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 8.7478% of the shares, which is about 0.57 million shares worth $0.84 million.
GEODE CAPITAL MANAGEMENT, LLC, with 0.7176% or 46648.0 shares worth $68572.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Apr 30, 2025 . The former held 34.71 shares worth $10288.0, making up 0.07% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 32.54 shares worth around $9645.0, which represents about 0.06% of the total shares outstanding.
